Drawing for QORE

USPTO serial 99213379

QORE

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
SHOOR, AMIT KUMAR
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with QORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $498*

Plus Government fees of $250

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ZACHARY AARON KNOX

ZACHARY AARON KNOX KNOX & ROSS LAW GROUP3661 Grand Ave., Ste. 205Oakland, CA 94610United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting services in the field of diversity and inclusion strategies for healthcare and biotechnology companies; business consultation in the field of developing and implementing strategic diversity initiatives for the healthcare sector; business advisory services relating to inclusive workforce development and employee resource group formation; consulting services in the field of inclusive marketing and communications strategies for healthcare organizations; business development consulting focused on inclusion-based innovation in healthcare and biotechnology; human resources consulting related to inclusive hiring, promotion, and retention practices for healthcare organizations; business management consulting for healthcare executives focused on implementing inclusive leadership practices; business consulting related to corporate social responsibility programming with an emphasis on healthcare equity; providing business data analytics services regarding diversity metrics and inclusion key performance indicators for healthcare organizations; none of the foregoing pertaining to genomics, DNA, RNA, sequencing, precision medicine, the practice of medicine, medical records, medical diagnostics, medical support, clinical care, clinical decision support, population health management utilizing genomic or biological data, virology research, epidemiology research, genealogy, or scientific research in the fields of genomics, genetics, or related biological sciences.ACTIVE—
041Educational services, namely, conducting workshops, seminars, and training in the field of inclusive research practices for healthcare and biotechnology; training services in the field of developing inclusive corporate cultures within healthcare organizations; motivational speaking services related to diversity, inclusion, and innovation in healthcare; arranging and conducting educational conferences in the field of healthcare inclusion; leadership development training for healthcare executives with emphasis on inclusive management techniques; educational mentorship programs focused on underrepresented populations in healthcare and biotechnology; providing non-downloadable webinars in the field of inclusive research methodologies; educational coaching services for healthcare organizations implementing diversity initiatives; arranging and conducting educational panel discussions related to inclusive healthcare innovation; educational services in the form of customized corporate training programs addressing inclusion challenges specific to the healthcare sector; none of the foregoing pertaining to genomics, DNA, RNA, sequencing, precision medicine, the practice of medicine, medical records, medical diagnostics, medical support, clinical care, clinical decision support, population health management utilizing genomic or biological data, virology research, epidemiology research, genealogy, or scientific research in the fields of genomics, genetics, or related biological sciences.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 29, 2026NOACCORRECTED NOA E-MAILED—
Jun 29, 2026CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Jun 27, 2026APETASSIGNED TO PETITION STAFF—
May 12, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 11, 2026EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Mar 17, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 17, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 24, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 27, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 27, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 27, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2025DOCKASSIGNED TO EXAMINER—
Oct 8, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 8, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 2, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 2, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance